Passage Bio, Inc. (NASDAQ:PASG – Get Free Report) major shareholder Lynx1 Capital Management Lp purchased 373,645 shares of ...

Galafold (migalastat) is an oral precision medicine for adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase ... that causes an enzyme deficiency.

The importance of a healthy gut for overall well-being cannot be overstated, made evident by the rising popularity of digestive enzyme supplements ... of alpha-galactosidase and beta-glucanase ...

Nizubaglustat is under clinical development by Azafaros and currently in Phase I for GM1 Gangliosidosis (Beta Galactosidase 1 Deficiency). According to GlobalData, Phase I drugs for GM1 Gangliosidosis ...

Zach began writing for CNET in November, 2021 after writing for a broadcast news station in his hometown, Cincinnati, for five years. You can usually find him reading and drinking coffee or ...

Apple has released iOS 18.3 public beta 1 today. The new beta offers a preview of the iPhone’s next software update to members of Apple’s beta software program. Here’s what to expect from ...

Babies born in the new year, and for the 14 years following, will make up the newest generation: Generation Beta. Its members will explore new digital landscapes, many of which we likely can't ...

Amicus Therapeutics' shares are down 15% recently despite a profitable Q3 2024 and raised FY2024 outlook. Click here to find ...

T-Mobile today said it opened registration for the "T-Mobile Starlink" beta service that will enable text messaging via satellites in dead zones not covered by cell towers. T-Mobile's announcement ...

Although signing up through this process gets you into the pool of test candidates, it does not guarantee that you’ll be among the lucky people being chosen to take part in the beta. Gryphline ...

Samsung has started rolling out the One UI 7 beta 2 update. The new update brings a host of bug fixes and performance improvements. One UI 7 beta 2 is now rolling out in the US, UK, Germany ...